| • |
MAS-1 is a proprietary, potent, stable and
safe water-in-oil adjuvant system developed
specifically for water-soluble protein-based
antigens. |
| • |
MAS-1 provides a unique, robust, readily
scaleable vehicle for the formulation of injectable
emulsions containing target antigens. |
| • |
MAS-1 is especially effective with soluble
antigens that are otherwise poorly antigenic
and has been specifically designed for use
in therapeutic vaccines. |
MAS-1 has been developed working closely with
FDA and other regulatory authorities and has been
used safely in more than 1,500 patients in a number
of clinical trials worldwide.
Mercia will provide clients with access to the
extensive preclinical pharmacology and toxicology
data, clinical pharmacodynamic and safety data,
and manufacturing and stability information through
access to a confidential Drug
Master File to support third party product
licensure.
The regulatory information available on MAS-1
facilitates a product’s entry into clinical
trials and is sufficiently comprehensive to support
full product licensure.
MAS-1 is available for product formulations through
Mercia's contract manufacturing services.
|
